These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 34472583)
41. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts. Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200 [TBL] [Abstract][Full Text] [Related]
42. Antepartum SARS-CoV-2 infection and adverse birth outcomes in South African women. Nunes MC; Jones S; Strehlau R; Baba V; Ditse Z; da Silva K; Bothma L; Serafin N; Baillie VL; Kwatra G; Burke M; Wise A; Adam M; Mlandu P; Melamu M; Phelp J; Fraser W; Wright C; Zell E; Adam Y; Madhi SA J Glob Health; 2022 Dec; 12():05050. PubMed ID: 36462199 [TBL] [Abstract][Full Text] [Related]
43. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study. Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261 [TBL] [Abstract][Full Text] [Related]
44. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial. Chowdary P; Angchaisuksiri P; Apte S; Astermark J; Benson G; Chan AKC; Jiménez Yuste V; Matsushita T; Høgh Nielsen AR; Sathar J; Sutton C; Šaulytė Trakymienė S; Tran H; Villarreal Martinez L; Wheeler AP; Windyga J; Young G; Thaung Zaw JJ; Eichler H Lancet Haematol; 2024 Dec; 11(12):e891-e904. PubMed ID: 39521008 [TBL] [Abstract][Full Text] [Related]
45. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome M; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C Lancet; 2022 Jan; 399(10323):437-446. PubMed ID: 35065011 [TBL] [Abstract][Full Text] [Related]
46. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis. Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485 [TBL] [Abstract][Full Text] [Related]
47. Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations. Serwanga J; Ankunda V; Katende JS; Baine C; Oluka GK; Odoch G; Nantambi H; Mugaba S; Namuyanja A; Ssali I; Ejou P; Kato L; ; Musenero M; Kaleebu P Front Immunol; 2024; 15():1348905. PubMed ID: 38357547 [TBL] [Abstract][Full Text] [Related]
48. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. Liu X; Munro APS; Wright A; Feng S; Janani L; Aley PK; Babbage G; Baker J; Baxter D; Bawa T; Bula M; Cathie K; Chatterjee K; Dodd K; Enever Y; Fox L; Qureshi E; Goodman AL; Green CA; Haughney J; Hicks A; Jones CE; Kanji N; van der Klaauw AA; Libri V; Llewelyn MJ; Mansfield R; Maallah M; McGregor AC; Minassian AM; Moore P; Mughal M; Mujadidi YF; Belhadef HT; Holliday K; Osanlou O; Osanlou R; Owens DR; Pacurar M; Palfreeman A; Pan D; Rampling T; Regan K; Saich S; Saralaya D; Sharma S; Sheridan R; Stokes M; Thomson EC; Todd S; Twelves C; Read RC; Charlton S; Hallis B; Ramsay M; Andrews N; Lambe T; Nguyen-Van-Tam JS; Cornelius V; Snape MD; Faust SN; J Infect; 2023 Jul; 87(1):18-26. PubMed ID: 37085049 [TBL] [Abstract][Full Text] [Related]
49. Human placental cells are resistant to SARS-CoV-2 infection and replication. Yoshida N; Thomas JR; Appios A; Brember MP; Aye ILMH; Edgar JR; Firth AE; Chung BYW; McGovern N; Stewart H Wellcome Open Res; 2024; 9():209. PubMed ID: 39640372 [TBL] [Abstract][Full Text] [Related]
50. Emotional literacy programme in special schools for children with a learning disability in England: the ZF-SEND feasibility RCT. Stenfert Kroese B; Unwin G; Hastings R; Jahoda A; McNamara R; Gillespie D; Segrott J; Ingarfield K; Gianatsi M; Randell E; Mather Z; Barrett B; Ganguli P; Rose J; Sahle M; Warren E; Da Cruz N Public Health Res (Southampt); 2024 Dec; 12(15):1-105. PubMed ID: 39641743 [TBL] [Abstract][Full Text] [Related]
51. Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model. Tomlinson E; Ward M; Cooper C; James R; Stokes C; Begum S; Watson J; Hay AD; Jones HE; Thom H; Whiting P Health Technol Assess; 2024 Nov; 28(77):1-109. PubMed ID: 39644102 [TBL] [Abstract][Full Text] [Related]
52. Infliximab for maintenance of medically-induced remission in Crohn's disease. Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447 [TBL] [Abstract][Full Text] [Related]
53. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives. Baker RR; Pereira da Silva JR; Smith G Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836 [TBL] [Abstract][Full Text] [Related]
54. Interventions to improve mental health and well-being in care-experienced children and young people aged less than 25: the CHIMES systematic review. Evans R; MacDonald S; Trubey R; Noyes J; Robling M; Willis S; Vinnicombe S; Boffey M; Wooders C; El-Banna A; Melendez-Torres GJ Public Health Res (Southampt); 2024 Dec; 12(14):1-124. PubMed ID: 39641478 [TBL] [Abstract][Full Text] [Related]
55. Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice. Zhu J; Wang Z; Li Y; Zhang Z; Ren S; Wang J; Xie S; Liao Z; Song B; Wu W; Yan F; Peng C J Virol; 2024 Jul; 98(7):e0052124. PubMed ID: 38874361 [TBL] [Abstract][Full Text] [Related]
56. Interventions for preventing weight gain after smoking cessation. Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006219. PubMed ID: 34611902 [TBL] [Abstract][Full Text] [Related]
57. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice. Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242 [TBL] [Abstract][Full Text] [Related]
58. Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults. Brown R; Cherian K; Jones K; Wickham R; Gomez R; Sahlem G Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015040. PubMed ID: 39092744 [TBL] [Abstract][Full Text] [Related]
59. Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study. Zhang Z; Bi Q; Fang S; Wei L; Wang X; He J; Wu Y; Liu X; Gao W; Zhang R; Gong W; Su Q; Azman AS; Lessler J; Zou X Lancet Microbe; 2021 Feb; 2(2):e79-e87. PubMed ID: 33495759 [TBL] [Abstract][Full Text] [Related]